IBDEI0TE ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,13784,2)
 ;;=^5009621
 ;;^UTILITY(U,$J,358.3,13785,0)
 ;;=M86.20^^53^595^62
 ;;^UTILITY(U,$J,358.3,13785,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13785,1,3,0)
 ;;=3^Osteomyelitis,Subacute,Unspec Site
 ;;^UTILITY(U,$J,358.3,13785,1,4,0)
 ;;=4^M86.20
 ;;^UTILITY(U,$J,358.3,13785,2)
 ;;=^5014535
 ;;^UTILITY(U,$J,358.3,13786,0)
 ;;=M86.10^^53^595^58
 ;;^UTILITY(U,$J,358.3,13786,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13786,1,3,0)
 ;;=3^Osteomyelitis,Acute,Unspec Site
 ;;^UTILITY(U,$J,358.3,13786,1,4,0)
 ;;=4^M86.10
 ;;^UTILITY(U,$J,358.3,13786,2)
 ;;=^5014521
 ;;^UTILITY(U,$J,358.3,13787,0)
 ;;=M86.00^^53^595^57
 ;;^UTILITY(U,$J,358.3,13787,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13787,1,3,0)
 ;;=3^Osteomyelitis,Acute Hematogenous,Unspec Site
 ;;^UTILITY(U,$J,358.3,13787,1,4,0)
 ;;=4^M86.00
 ;;^UTILITY(U,$J,358.3,13787,2)
 ;;=^5014497
 ;;^UTILITY(U,$J,358.3,13788,0)
 ;;=M86.50^^53^595^59
 ;;^UTILITY(U,$J,358.3,13788,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13788,1,3,0)
 ;;=3^Osteomyelitis,Chronic Hematogenous,Unspec Site
 ;;^UTILITY(U,$J,358.3,13788,1,4,0)
 ;;=4^M86.50
 ;;^UTILITY(U,$J,358.3,13788,2)
 ;;=^5014607
 ;;^UTILITY(U,$J,358.3,13789,0)
 ;;=M86.30^^53^595^60
 ;;^UTILITY(U,$J,358.3,13789,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13789,1,3,0)
 ;;=3^Osteomyelitis,Chronic Multifocal,Unspec Site
 ;;^UTILITY(U,$J,358.3,13789,1,4,0)
 ;;=4^M86.30
 ;;^UTILITY(U,$J,358.3,13789,2)
 ;;=^5014559
 ;;^UTILITY(U,$J,358.3,13790,0)
 ;;=M86.8X9^^53^595^63
 ;;^UTILITY(U,$J,358.3,13790,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13790,1,3,0)
 ;;=3^Osteomyelitis,Unspec Sites
 ;;^UTILITY(U,$J,358.3,13790,1,4,0)
 ;;=4^M86.8X9
 ;;^UTILITY(U,$J,358.3,13790,2)
 ;;=^5014655
 ;;^UTILITY(U,$J,358.3,13791,0)
 ;;=M86.60^^53^595^61
 ;;^UTILITY(U,$J,358.3,13791,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13791,1,3,0)
 ;;=3^Osteomyelitis,Chronic,Unspec Site
 ;;^UTILITY(U,$J,358.3,13791,1,4,0)
 ;;=4^M86.60
 ;;^UTILITY(U,$J,358.3,13791,2)
 ;;=^5014630
 ;;^UTILITY(U,$J,358.3,13792,0)
 ;;=M86.40^^53^595^56
 ;;^UTILITY(U,$J,358.3,13792,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13792,1,3,0)
 ;;=3^Osteomyelitis w/ Draining Sinus,Chronic,Unspec Site
 ;;^UTILITY(U,$J,358.3,13792,1,4,0)
 ;;=4^M86.40
 ;;^UTILITY(U,$J,358.3,13792,2)
 ;;=^5014583
 ;;^UTILITY(U,$J,358.3,13793,0)
 ;;=R50.2^^53^595^23
 ;;^UTILITY(U,$J,358.3,13793,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13793,1,3,0)
 ;;=3^Fever,Drug-Induced
 ;;^UTILITY(U,$J,358.3,13793,1,4,0)
 ;;=4^R50.2
 ;;^UTILITY(U,$J,358.3,13793,2)
 ;;=^5019507
 ;;^UTILITY(U,$J,358.3,13794,0)
 ;;=R50.9^^53^595^27
 ;;^UTILITY(U,$J,358.3,13794,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13794,1,3,0)
 ;;=3^Fever,Unspec
 ;;^UTILITY(U,$J,358.3,13794,1,4,0)
 ;;=4^R50.9
 ;;^UTILITY(U,$J,358.3,13794,2)
 ;;=^5019512
 ;;^UTILITY(U,$J,358.3,13795,0)
 ;;=R76.11^^53^595^1
 ;;^UTILITY(U,$J,358.3,13795,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13795,1,3,0)
 ;;=3^Abnormal Reaction to TB Test w/o Active TB
 ;;^UTILITY(U,$J,358.3,13795,1,4,0)
 ;;=4^R76.11
 ;;^UTILITY(U,$J,358.3,13795,2)
 ;;=^5019570
 ;;^UTILITY(U,$J,358.3,13796,0)
 ;;=Z21.^^53^595^30
 ;;^UTILITY(U,$J,358.3,13796,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13796,1,3,0)
 ;;=3^HIV Asymptomatic,Infection Status
 ;;^UTILITY(U,$J,358.3,13796,1,4,0)
 ;;=4^Z21.
 ;;^UTILITY(U,$J,358.3,13796,2)
 ;;=^5062777
 ;;^UTILITY(U,$J,358.3,13797,0)
 ;;=B37.0^^53^595^16
 ;;^UTILITY(U,$J,358.3,13797,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13797,1,3,0)
 ;;=3^Candidal Stomatitis (Oral Thrush)
 ;;^UTILITY(U,$J,358.3,13797,1,4,0)
 ;;=4^B37.0
